Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
54.75 EUR | -0.09% |
|
+0.92% | -3.01% |
01/07 | US FDA Approves Formycon's Biosimilar to Treat Serious Retinal Diseases | MT |
18/06 | Borse Frankfurt-News: Many winners and many losers (second-line stocks) | DP |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.01% | 1.05B | |
+16.59% | 44.44B | |
+41.98% | 39.84B | |
-10.62% | 37.68B | |
+29.92% | 31.46B | |
-9.78% | 27.02B | |
+12.34% | 26.29B | |
+41.53% | 13.8B | |
+31.49% | 12.46B | |
-7.40% | 11.26B |
- Stock Market
- Equities
- FYB Stock
- News Formycon AG
- US FDA Approves Formycon's Biosimilar to Treat Serious Retinal Diseases